Open Access

Characterization of a novel chaperone/usher fimbrial operon present on KpGI-5, a methionine tRNA gene-associated genomic island in Klebsiella pneumoniae

  • Jon J van Aartsen1,
  • Steen G Stahlhut2,
  • Ewan M Harrison1,
  • Marialuisa Crosatti1,
  • Hong-Yu Ou3,
  • Karen A Krogfelt2,
  • Carsten Struve2 and
  • Kumar Rajakumar1, 4Email author
BMC Microbiology201212:59

https://doi.org/10.1186/1471-2180-12-59

Received: 30 October 2011

Accepted: 20 April 2012

Published: 20 April 2012

Abstract

Background

Several strain-specific Klebsiella pneumoniae virulence determinants have been described, though these have almost exclusively been linked with hypervirulent liver abscess-associated strains. Through PCR interrogation of integration hotspots, chromosome walking, island-tagging and fosmid-based marker rescue we captured and sequenced KpGI-5, a novel genomic island integrated into the met56 tRNA gene of K. pneumoniae KR116, a bloodstream isolate from a patient with pneumonia and neutropenic sepsis.

Results

The 14.0 kb KpGI-5 island exhibited a genome-anomalous G + C content, possessed near-perfect 46 bp direct repeats, encoded a γ1-chaperone/usher fimbrial cluster (fim2) and harboured seven other predicted genes of unknown function. Transcriptional analysis demonstrated expression of three fim2 genes, and suggested that the fim2A-fim2K cluster comprised an operon. As fimbrial systems are frequently implicated in pathogenesis, we examined the role of fim2 by analysing KR2107, a streptomycin-resistant derivative of KR116, and three isogenic mutants (Δfim, Δfim2 and ΔfimΔfim2) using biofilm assays, human cell adhesion assays and pair-wise competition-based murine models of intestinal colonization, lung infection and ascending urinary tract infection. Although no statistically significant role for fim2 was demonstrable, liver and kidney CFU counts for lung and urinary tract infection models, respectively, hinted at an ordered gradation of virulence: KR2107 (most virulent), KR2107∆fim2, KR2107∆fim and KR2107∆fimfim2 (least virulent). Thus, despite lack of statistical evidence there was a suggestion that fim and fim2 contribute additively to virulence in these murine infection models. However, further studies would be necessary to substantiate this hypothesis.

Conclusion

Although fim2 was present in 13% of Klebsiella spp. strains investigated, no obvious in vitro or in vivo role for the locus was identified, although there were subtle hints of involvement in urovirulence and bacterial dissemination from the respiratory tract. Based on our findings and on parallels with other fimbrial systems, we propose that fim2 has the potential to contribute beneficially to pathogenesis and/or environmental persistence of Klebsiella strains, at least under specific yet-to-be identified conditions.

Background

Klebsiella pneumoniae is a Gram negative member of the Enterobacteriaceae family that commonly causes nosocomial pneumonia, bacteriaemia, urinary tract infections and wound infections [1]. In recent years the treatment of K. pneumoniae infections has become more challenging due to the greater prevalence of multiple antibiotic resistant strains [2, 3]. Moreover, hypervirulent, pyogenic liver abscess-causing K. pneumoniae strains that infect otherwise healthy individuals have emerged from initial endemic foci in Taiwan and China, and are now spreading into North America and Europe [46]. This highlights the increasing threat that K. pneumoniae poses to public health and the importance of elucidating its mechanisms of pathogenesis.

Most K. pneumoniae strains possess a thick polysaccharide capsule which is involved in protection from opsonisation and phagocytosis and is a well recognized in vivo virulence factor [7]. Various studies have also highlighted roles for surface-exposed lipopolysaccharides, multiple iron acquisition systems and adhesins in K. pneumoniae infection [1, 7, 8]. Several strain-specific virulence determinants of the pyogenic liver abscess-associated isolate K. pneumoniae NTUH-K2044 have been well characterised [911]. However, the functions of strain-specific genomic regions in K. pneumoniae strains associated with other types of infection remain poorly studied.

Comparative analyses using computational and in vitro experimental techniques have shown that K. pneumoniae strains possess an extremely plastic genome that consists of a conserved core genome interspersed by strain-specific accessory components [1215]. This was further highlighted in a recent study which calculated that only 54.7% of known K. pneumoniae genes were shared by three sequenced isolates (Kp342, MGH78578, NTUH-K2044) [15]. Genomic islands (GI), typically ranging from 10 kb to 200 kb in size and frequently inserted within tRNA gene (tRNA) hotspots, comprise a substantial proportion of the accessory genome. GI acquisition offers an efficient ‘quantum leap’ based route to gaining virulence factors, antibiotic resistance determinants and/or metabolic pathways pre-tailored for the exploitation of new environments [16, 17].

Epidemiological studies have suggested that K. pneumoniae infections are preceded by colonization of the gastrointestinal tract [18]. Adhesion and colonization are essential steps in the infection process and are often mediated by fimbriae, which are small hair-like extensions on the bacterial cell surface that can interact with other surfaces via tip-located adhesin proteins [19]. The majority of environmental and clinical K. pneumoniae isolates are known to express type 1 fimbriae and type 3 fimbriae, which have recently been classified into the γ1 and γ4-fimbrial subgroups using the Nuccio and Bäumler fimbrial classification system, which was created from a large scale phylogenetic analysis of fimbrial usher proteins [2023]. Recent in vivo experiments have demonstrated a role for K. pneumoniae type 1 fimbriae in urinary tract infections [22]. Although type 3 fimbriae have been shown to enhance biofilm formation and mediate attachment to bladder epithelium in vitro, the role of these structures in vivo has yet to be determined as an isogenic mrk knockout strain was as virulent as its wildtype parent in murine pneumonia and urinary tract infection models [23, 24].

K. pneumoniae type 1 and type 3 fimbriae are both thought to assemble via the chaperone/usher (CU) assembly pathway which has been characterised in detail for the archetypal E. coli type 1 and P fimbriae [25]. Some CU fimbriae, such as the Kpc fimbriae of K. pneumoniae NTUH-K2044, are encoded by only a subset of strains and are thought to potentially correlate with tropism towards particular host tissues and infection types [26]. Many strain-specific fimbriae are encoded on tRNA gene-associated GIs, best illustrated by the saf tcf sef std and stb fimbrial operons of Salmonella enterica serovar Typhi strain CT18. This latter strain encodes an arsenal of twelve putative CU fimbrial operons that are hypothesized to correlate with adaptation to the human host [27]. The genomes of K. pneumoniae Kp342, MGH78578 and NTUH-K2044 contain nine, eleven and eight CU fimbrial operons, respectively, though the originally described type 1 and type 3 fimbrial operons are common to all three [26]. Apart from the serotype K1-associated kpc operon, no studies have investigated the in vitro and/or in vivo role of other K. pneumoniae accessory fimbrial operons. We now describe the identification, genetic characterization and initial functional analysis of a novel CU fimbrial operon (fim2) that is encoded on a previously unidentified GI, KpGI-5, found inserted within the met56 tRNA gene of K. pneumoniae strain KR116.

Results

The KpGI-5 genomic island codes for a novel predicted chaperone/usher fimbrial system

Whilst screening five tRNA gene insertion hotspots in sixteen clinical K. pneumoniae isolates for strain-specific DNA using a technique called tRIP-PCR [13, 14], we found that K. pneumoniae KR116 possessed an ‘occupied’ met56 tRNA locus. tRIP-PCR using primers PR601 and PR647, which were designed to amplify across the met56 tRNA locus, failed to amplify a product in KR116. Single genome-specific primer based walking from the conserved met56 upstream flank yielded ~3 kb of novel sequence.

To capture and sequence this entire strain-specific island, we tagged the known tRNA-proximal arm of the island with a kanamycin resistance cassette using allelic exchange. A fosmid library of this tagged strain (KR116 ∆fim2K::kan) was then created and used to isolate kanamycin resistance cassette-bearing inserts by marker rescue. Two overlapping fosmids, pJFos-1 and pJFos-4, shown by end-sequencing to span the entire strain-specific region were sequenced to define this novel KR116 met56-specific GI that we designated KpGI-5.

KpGI-5 is a 14.0 kb insertion at the met56 locus of KR116 with many features in common with typical GIs. Firstly, the calculated G + C content (44.0%) was much lower than the corresponding genome averaged values of K. pneumoniae MGH78578 (57.5%) and Kp342 (57.3%). Secondly, the island was present downstream of the K. pneumoniae met56 gene, which is a proven hotspot for GI integration [15]. And finally, the island possessed an almost perfect 46 bp direct repeat that corresponded to the 3’ end of met56. However, no putative integrase or mobility-associated genes were identified. Open reading frame (ORF) and BLAST analyses were performed on the KpGI-5 sequence (Figure 1 and Table 1). The 2.7 kb segment mapping to the right arm of KpGI-5 was 90% identical to a region immediately downstream of met56 in K. pneumoniae Kp342 and was predicted to encode two hypothetical proteins (Orf14 and Orf15), a metallo-beta-lactamase family protein (Orf16) and a putative GCN5-related N-acetyltransferase (Orf13). The nucleotide sequence of a 3.4 kb central region did not match any GenBank entries and coded for three novel proteins; Orf10 and Orf11 exhibited weak matches to putative regulatory proteins from the bacteria Stigmatella aurantiaca DW4/3-1 and Serratia odorifera DSM 4582, respectively. Orf10 also possessed a match to the pfam domain Trans_reg_C (PF00486) which has been implicated in DNA binding, further suggesting a role for Orf10 in regulation.
Figure 1

Features of the novel KpGI-5 genomic island in K. pneumoniae KR116. (A) Genetic organisation of KpGI-5 shown lying between the species-conserved upstream flank (UF) and downstream flank (DF) sequences. The eight putative fimbrial genes are labelled fim2Afim2K. Closest BLASTP similarities for these and other predicted KpGI-5-encoded proteins are described in Table 1. KpGI-5 segments indicated by double arrows map to G + C % transitions as indicated by G + C profile. The thin horizontal lines on the G + C % graph represent the average G + C content of the K. pneumoniae MGH78578 genome (57.4%) and the entire KpGI-5 island (44.0%). The 20.8% and 65.0% G + C content lines correspond to the minimum and maximum G + C % calculated over an 80 bp window, respectively. (B) Alignment of the tRNA-proximal (DRP) and tRNA-distal (DRD) 46 bp direct repeat (DR) sequences associated with KpGI-5. DRP comprises the 3’ end of met56.

Table 1

BLASTP homologs of proteins predicted to be encoded by KpGI-5

Gene name

Coding region (bp)

Protein size (aaa)

Percentage identity (aaa)

Organism

Possible function

[GenBank Number]

E value

met56

180..255 (76)

/

100% (note: BLASTN)

K. pneumoniae MGH78578

Methionine tRNA [KPN_03476]

/

fim2K

1385..528 (858)

285

60% (165/276)

C. koseri ATCC BAA-895

Putative EAL domain protein [ABV14791.1]

1e-94

fim2H

2440..1514 (927)

308

62% (190/308)

K. pneumoniae sp15

Fimbrial adhesin (FimH) [ACL13802.1]

1e-101

fim2G

2961..2458 (504)

167

72% (120/167)

C. koseri ATCC BAA-895

Minor fimbrial subunit (FimG) [ABV14789.1]

2e-65

fim2F

3501..2974 (528)

175

79% (138/175)

C. koseri ATCC BAA-895

Minor fimbrial subunit (FimF) [ABV14788.1]

1e-73

fim2D

6073..3515 (2559)

852

82% (689/838)

C. koseri ATCC BAA-895

Outer membrane usher protein (FimD) [ABV14787.1]

0.0

fim2C

6858..6229 (630)

209

92% (190/207)

K. variicola At-22

Fimbrial chaperone protein (FimC) [ADC56706.1]

2e-107

fim2I

7519..6989 (531)

176

82% (139/170)

C. koseri ATCC BAA-895

Fimbrial protein (FimI) [ABV14784.1]

2e-80

fim2A

8148..7600 (549)

182

88% (160/182)

K. pneumoniae MGH 78578

Major fimbrial protein (FimA) [ABR78685.1]

1e-79

orf10

9002..8355 (648)

215

37% (24/65)

S. aurantiaca DW4/3-1

Putative two component system regulatory protein [EAU69265.1]

0.019

orf11

9409..10254 (846)

281

28% (77/277)

S. odorifera DSM 4582

Putative transcriptional regulatory protein [EFE96725.1]

3e-20

orf12

10251..10727 (477)

158

29% (38/130)

S. odorifera DSM 4582

Hypothetical protein [EFE96270.1]

1e-13

orf13

12266..11694 (573)

190

97% (184/190)

Klebsiella sp. 1_1_55

Putative GCN5-related N-acetyltransferase [EFD84432.1]

1e-106

orf14

12387..12268 (120)

39

100% (39/39)

K. pneumoniae 342

Hypothetical protein [ACI07992.1]

1e-12

orf15

12616.. 12359 (234)

77

92% (71/77)

K. pneumoniae 342

Hypothetical protein [ACI06987.1]

1e-34

orf16

13342..14187 (846)

281

91% (256/281)

K. pneumoniae 342

Metallo-beta-lactamase family protein [ACI07748.1]

1e-151

a aa, amino acids.

The 7.9 kb left arm of KpGI-5 harboured a novel eight-gene cluster that exhibited sequence similarity and organizational-identity to the chromosomally-encoded fim operons of Citrobacter koseri ATCC BAA-895 (~60%) and K. pneumoniae C3091 (~51%). This cluster was named fim2. It encoded homologs of all structural and biosynthesis-associated components of the well-characterized C3091 type 1 fimbrial system, including a major fimbrial subunit (Fim2A), three minor fimbrial subunits (Fim2F, Fim2G and Fim2H), and a chaperone (Fim2C) and usher (Fim2D) protein [22]. Downstream of fim2H was fim2K which encoded a FimK homolog that possessed a matching EAL domain but lacked a FimK-equivalent N-terminal helix-turn-helix domain. EAL domains have been implicated in the hydrolysis of c-di-GMP, an intracellular messenger that regulates important cellular functions including different forms of motility, adhesin and exopolysaccharide matrix synthesis, fimbrial expression and virulence [2832]. Helix-turn-helix domains are associated with binding to specific DNA sequences and in the context of EAL domain-bearing proteins are hypothesized to modulate the c-di-GMP hydrolytic activity of these proteins [30]. Amino acid sequence identities between cognate fim2 and fim products varied from 60 – 92%. However, no homologs of the C3091 fimB fimE or fimS invertible promoter switch could be identified upstream of fim2. K. pneumoniae KR116 also possessed the species-conserved fim and mrk operons, as shown by PCR screening for the fimH and mrkD adhesin genes using primer pairs PR1144-PR1145 and PR1150-PR1151, respectively. Of note, the G + C content of the fim2 operon (47.7%) was much lower than that of the K. pneumoniae fim operon (60.8%) and quite distinct from the G + C content of the four fully sequenced K. pneumoniae genomes (56.9% – 57.4%).

The KpGI-5 fim2 locus is found within several Klebsiella spp. and is globally distributed

To determine the prevalence of fim2 in Klebsiella spp., a total of 162 strains (123 K. pneumoniae, 19 undefined Klebsiella spp., 18 K. oxytoca, one K. ornithinolytica and one K. planticola) isolated from distinct sources were PCR screened for fim2K using primers PR615-PR616. In total, 21 out of 162 strains (13.0%) were identified to be fim2 positive, including 16 K. pneumoniae (16/123 = 13.0%), three undefined Klebsiella spp. (3/19 = 15.7%) and two K. oxytoca (2/18 = 11.1%). It must be noted that these species designations are based on biochemical species identifications, which can be problematic in this genus [33]. 93.4% (15/16) of fim2-positive K. pneumoniae strains were also found to be mrk- and fim-positive by PCR analysis. However, the distribution of the latter were not investigated in other Klebsiella spp. due to recognized species-specific differences in fim and mrk operon sequences [34].

Further examination suggested that the specimen type from which strains were obtained was not a predictor of the presence or absence of fim2 (Table 2). Notably, fim2-positive strains were not limited to one geographical area. KR116, the index fim2-positive strain, was isolated in the United Kingdom, while other fim2-bearing strains were isolated in Germany, Denmark, USA and China, suggesting a sporadic but global spread of the fim2 locus.
Table 2

Prevalence of fim2 by specimen type

 

Totala

fim2+b

Percentagec

Ascitic fluid

9

1

11.1%

Biliary fluid

1

0

0%

Blood

48

8

16.7%

Cerebrospinal fluid

2

0

0%

Environmental

11

1

9.0%

Pyogenic liver abscess aspirates

11

0

0%

Nasopharynx

3

0

0%

Sputum

11

1

9.0%

Unknown

20

4

20.0%

Urine

45

5

11.1%

Wound

1

1

100%

All

162

21

13.0%

a Total number of strains tested.

b Total number of strains testing fim2-positive using primers PR615 and PR616.

c Percentage of fim2-positive strains.

Fim2 genes are expressed under standard in vitro growth conditions

Many chaperone/usher operons are poorly expressed under laboratory conditions [35, 36]. To investigate fim2 expression, RNA was isolated from KR2107, a streptomycin-resistant derivative of KR116, which had been cultured in LB medium for 16 h (37°C, 200 rpm) and a cDNA library constructed using random primer-based RT-PCR. Subsequent PCR analysis of this cDNA library detected transcripts that corresponded to fim2A fim2H and fim2K, while reverse transcriptase-free control reaction mixtures did not yield any products, thus confirming absence of DNA carryover (Figure 2). Follow-up quantitative-PCR experiments on this KR2107 cDNA library showed that under the growth conditions examined fim2A was expressed approximately 30- and 90-fold less than fimA and mrkA, respectively (data not shown). As PCR analysis spanning orf10 to fim2A did not yield a product, whilst that linking fim2H to fim2K produced a specific band, it would appear that the eight gene fim2 cluster was expressed as a single transcript and that orf10 gene was not part of this transcriptional unit (Figure 2). Of note, transcripts corresponding to fim2A fim2H and fim2K were also detected in KR2107 grown at 37°C for 16 h (200 rpm) in M9 minimal media plus 0.2% glycerol, RPMI 1640, RPMI 1640 plus 10% fetal calf serum and King’s B medium (data not shown).
Figure 2

Transcriptional analysis of fim2 . A schematic map of the fim2 cluster and the upstream orf10 gene to show regions targeted for transcriptional analysis: fim2K (PCR-1, 220 bp: PR1611/PR1612), fim2H-fim2K (PCR-2, 316 bp: PR16268/PR1629), fim2H (PCR-3, 241 bp: PR1609/PR1610), fim2A (PCR-4, 221 bp: PR1607/PR1608) and fim2A-orf10 (PCR-5, 380 bp: PR1626/PR1627). RNA purified from an in vitro grown culture of KR2107 (LB, 37°C, 200 rpm, 16 h) was processed in parallel with (+) or without (−) reverse transcriptase and analysed by PCR with the primers listed above. KR2107 genomic DNA (g) and PCR-grade water (Neg) were used as PCR controls when necessary. Amplicons were visualised on 1.5% agarose gels. Distinct PCR amplicons were obtained for four of the five assays. The PCR-5 assay which sought to define a shared orf10 and fim2A transcript was negative.

Heterologous expression of fim2 does not result in visualisable host fimbriation

The fim2 locus was PCR-amplified from KR116 and cloned into the high copy number vector pBluescript II KS+, the low copy number vector pWSK129 and the PTRC-bearing vector pJTOOL-7 to create pFim2-HCN, pFim2-LCN and pFim2-Ptrc, respectively. Each plasmid was transformed into the afimbriate E. coli strain HB101 and examined by electron microscopy in an attempt to visualise the putative Fim2 fimbriae. Despite use of multiple induction methods and over 100 cells being viewed per strain, no definite fimbrial structures could be identified on the bacterial surfaces examined. Similar results were obtained when the locus was expressed in a fim2-negative K. pneumoniae mutant, C3091ΔfimΔmrk. By contrast, HB101 possessing a pJTOOL-7 derivative with the fim operon expressed abundant and highly characteristic type 1 fimbriae on its outer surface. Notably, despite the absence of detectable fimbriation in E. coli HB101/pFim2-Ptrc induced with IPTG, major induction-associated growth reduction was observed (Figure 3A). HB101/pFim2-Ptrc growth inhibition exhibited a distinct dose–response relationship to IPTG concentration and this was not evident with the control strains HB101 and HB101/pJTOOL-7 (Figure 3B). By contrast, over-expression of fim appeared to enhance the growth rate of HB101/pFim-Ptrc but had no effect on final cell densities as compared to the above mentioned control strains.
Figure 3

IPTG induction of HB101/pFim2-Ptrc causes a major growth reduction. (A) Growth curves for HB101, HB101/pJTOOL-7 (empty vector), HB101/pFim-Ptrc and HB101/pFim2-Ptrc. The growth curves for HB101 and HB101/pJTOOL-7 are largely superimposed as these are very similar. (B) Growth curves for HB101/pFim2-Ptrc grown for 24 h in LB broth containing 100 μg/ml ampicillin supplemented with 0.0 mM, 0.05 mM or 0.1 mM IPTG. Data shown in all cases represent the means of two biological replicates, each assayed in seven wells (n = 14).

Expression of fim2 in E. coli HB101 appears to enhance biofilm formation

K. pneumoniae readily colonizes and forms biofilms on abiotic surfaces such as urinary catheters and tracheal tubes [21, 37]. As surface-expressed structures play a key role in biofilm formation, the ability of KR2107 and its isogenic mutants to form biofilms was examined. However, absence of fim2 and/or fim had no effect on biofilm formation as assayed at 24 h under static growth conditions in LB or M9 media at either 37°C or 30°C (Figure 4A; data not shown). To detect a potential contribution to biofilm formation that may have been masked by low-level fim2 expression or capsule-related physical hindrance of fimbrial function [38], fim2 was over-expressed from pFim2-Ptrc in E. coli HB101 using 0.05 mM IPTG induction. Compared to HB101 carrying the empty pJTOOL-7 vector, HB101/pFim2-Ptrc exhibited similar biofilm formation at 48 h on polystyrene wells as assessed by post-washing crystal violet staining (Figure 4B). On the other hand, expression of fim2 in HB101 resulted in marginally denser biofilm in polyvinyl chloride wells as compared to the vector-only control, but this was not statistically significant (P = 0.464; Figure 4B).
Figure 4

The fim2 locus appears to contribute to biofilm formation when expressed in E. coli HB101. (A) Results for biofilm formation assay on polystyrene for KR2107 and its three fim and/or fim2 isogenic mutants as determined by crystal violet absorbance data. Equivalent results, suggestive of no strain-to-strain differences, were obtained for assays on polyvinyl chloride plates (data not shown). (B) Biofilm formation assay based on heterologous expression of fim2 in E. coli HB101/pFim2-Ptrc. HB101 and HB101 carrying an empty pJTOOL-7 served as controls. Biofilm formation was quantified using crystal violet staining and absorbance was measured at 595 nm. Non-normalized crystal violet absorbance data are shown. (C) Biofilm formation assay results shown in (B) were normalized to take account of pre-wash total cell numbers based on OD595 readings performed at 48 h, just prior to washing off non-surface adherent cells and crystal violet staining. Data shown in all cases represent means and standard deviations of three biological replicates, each assayed in eight wells (n = 24). An asterisk indicates a highly significant difference (P < 0.0001) from HB101 and HB101/pJTOOL-7.

As HB101/pFim2-Ptrc grew to a much lower OD595 at 48 h than the other two strains, we also analysed the biofilm data as a ratio of crystal violet staining intensity to the pre-wash OD595 measurement that reflected total growth. This analysis suggested that the proportion of HB101/pFim2-Ptrc cells comprising biofilm growth as opposed to total growth (biofilm and planktonic cells) was almost twice that of HB101 and the vector only control strain (Figure 4C). Indeed, based on this ratio, fim2 expression in HB101 exerted a highly significant positive impact on biofilm formation on both surfaces (P < 0.0001 in each case). By contrast when fim2 was expressed in the Mrk- and Fim-deficient strain C3091∆fimmrk using this same system, no statistically significant accentuation in biofilm formation on either surface was observed (data not shown).

Deletion of fim2 does not affect adhesion to human HCT-8 ileocaecal or 5637 bladder epithelial cells

In vitro adhesion assays were performed to further investigate whether KR2107 and its three isogenic mutants (KR2107∆fim, KR2107∆fim2 and KR2107∆fimfim2) exhibited differing cell adhesion properties. Human HCT-8 ileocecal and human 5637 bladder epithelial cell lines were chosen to investigate adherence to intestine- and bladder-derived cells, respectively. No significant differences were detectable by these in vitro tissue culture assays (Figure 5). Furthermore, despite the previously reported impaired urovirulence of a fim-negative K. pneumoniae strain [22], the KR2107∆fim and KR2107∆fimfim2 mutants examined in this study did not display any defect in adherence to bladder epithelial cells relative to KR2107 or KR2107∆fim2. It is possible that fim and/or fim2 expression was insignificant under the in vitro conditions used or that the K. pneumoniae capsule interfered with fimbrial function [38, 39].
Figure 5

Cell-adherence properties of K. pneumoniae KR2107 and its isogenic fim and/or fim2 mutants. (A) In vitro adhesion assays to human HCT-8 ileocaecal cells. (B) In vitro adhesion assays to human 5637 bladder epithelial cells. In both cases percentages of bacteria that remained adherent to cell monolayers after 3 h of incubation at 37°C followed by careful washing are shown. Bars represent means and standard deviations.

Deletion of fim2 does not affect murine intestinal colonization

Epidemiological studies have elucidated that the first step in the majority of K. pneumoniae infections is gastrointestinal tract colonization [18]. To investigate whether fim2 influences this initial step, a 1:1 mixture of KR2107 and KR2107∆fim2 was fed to three mice and faecal CFU counts were monitored for 13 days. To exclude potential type 1 fimbriae-related masking, a competition experiment between KR2107∆fim and KR2107∆fimfim2 was also performed. As assessed by faecal CFU counts, no strain exhibited an obvious competitive advantage and all four strains were found to readily colonize the large intestine in similar numbers (~108 – 109 CFU/g) throughout the experiment (Figure 6). Apart from confirming that fim does not affect intestinal colonization [22], these results also suggested that fim2 does not play a significant role in murine intestinal colonization by K. pneumoniae.
Figure 6

Murine intestinal colonization of K. pneumoniae KR2107 and its isogenic fim and/or fim2 mutants. (A) Intestinal co-colonization following oral feeding with a 1:1 mixture of KR2107 and KR2107∆fim2. (B) Intestinal co-colonization following oral feeding with a 1:1 mixture of KR2107∆fim and KR2107∆fimfim2. Mean CFU/g faeces and corresponding standard deviation values are shown.

The fim2 locus is not a virulence factor in a murine lung infection model

K. pneumoniae is a clinically important cause of lung infections and various potential virulence factors have been determined [40, 41]. The influence of fim2 on pneumovirulence was investigated by intranasal inoculation of five mice with a mixture comprising equal numbers of KR2107 and KR2107∆fim2. An equivalent competition experiment between KR2107∆fim and KR2107∆fimfim2 was also performed. 30 h post-infection all mice displayed significant signs of disease and were sacrificed. High numbers of K. pneumoniae were found in the lungs of all mice (5 × 105 – 1 × 107 CFU/lung). Similar lung CFU counts were obtained for both competition assays. Furthermore, no significant deviation in fim2-positive to fim2-negative strain ratios was evident for either competition assay (Figure 7A). These data suggest that both fim and fim2 do not impact significantly on pneumovirulence of K. pneumoniae in a murine lung infection model.
Figure 7

Murine lung infection model studies with KR2107 and its isogenic fim and/or fim2 mutants. (A) Comparison of the ability of KR2107 and its isogenic mutants to infect the lungs as assessed by two head-to-head competition assays. A mixture containing an equal ratio of each competing strain was inoculated intranasally into five mice. The competitive index (CI) is the ratio of the number of fim2-positive to fim2-negative bacteria recovered from infected organs divided by the equivalent ratio as present in the intranasal inoculum. (B) Differential CFU counts for each of the competing strains in the liver at 30 h post-inoculation. (C) Liver CFU counts obtained in the five mice used for the competition assay between KR2107 and its isogenic fim2 mutant. In A and B, horizontal bars represent the median, with data points for each mouse as indicated. The lower limit of detection is represented by the dotted line. P values were calculated using the Mann–Whitney U test.

Total liver and spleen CFU counts were used as a measure of the ability of bacteria to disseminate from the lungs into the bloodstream. Much lower numbers and greater mouse-to-mouse variation occurred in CFU counts for the livers (<15 – 1.6 × 104) and spleens (<20 – 200) of these mice. The median CFU count per liver for KR2107 (2.1 × 103) was elevated compared to that of KR2107∆fim2 (3.0 × 101), although this difference was not significant (P = 0.340). When liver CFU counts were examined individually for each mouse, two mice exhibited greater than 1-log more KR2107 than KR2107∆fim2, while the difference, though still hinting at an advantage for KR2107, was less than 0.5 log for two other mice (Figure 7B and C). The liver CFU counts in mouse 3 for both strains were equal to the lower limit of detection and extrapolated from a single colony each, thus preventing meaningful comparison of these values. No difference was found between the median CFU counts per liver for KR2107∆fim and KR2107∆fimfim2 (1.5 × 101). Thus, despite the absence of firm conclusions emanating from these data, the possibility that fim2 may play a role in systemic dissemination and/or survival of K. pneumoniae following murine lung infection cannot be dismissed entirely.

Role of fim2 in a murine urinary tract infection model

Type 1 fimbriae are a well-established virulence factor of K. pneumoniae urinary tract infections [22, 23]. To assess the role of fim2 in K. pneumoniae urinary tract infection, a group of six mice were inoculated transurethrally with a 1:1 mixture of KR2107 and its fim2 mutant and sacrificed 3 days post-inoculation. All urine and bladder samples were found to be colonized and a median CFU count of 8.7 × 105 per bladder and 5.0 × 104 per ml of urine was obtained. In all mice the infection had ascended into the kidneys producing a median bacterial count of 5.3 × 103 per kidney (n = 12). The median CI value obtained for bladder samples indicates 10-fold more CFUs of KR2107 than the fim2 mutant (Figure 8A). These values are supported by the median kidney CFU count which was 10-fold higher for the wildtype (4.8 × 103) than the fim2 mutant (4.8 × 102), although this difference is not statistically significant (P = 0.285) (Figure 8B). Nevertheless, these concordant findings would suggest that fim2 may exert a subtle influence on the urovirulence of K. pneumoniae.
Figure 8

Murine urinary tract infection model studies with KR2107 and its isogenic fim and/or fim2 mutants. (A) Comparison of the urovirulence of KR2107 and its isogenic mutants as assessed by two head-to-head competition assays. A mixture containing approximately equal numbers of each competing strain was inoculated into the bladders of six mice. The competitive index (CI) is the ratio of the number of fim2-positive to fim2-negative bacteria recovered from urine or bladder divided by the equivalent ratio as present in the infecting inoculum. (B) Differential CFU counts for each of the competing strains in the left and right kidneys at 3 days post-inoculation. In both of the above analyses horizontal bars represent the median, with data points for each mouse as indicated. The lower limit of detection is represented by the dotted line. P values were calculated using the Mann–Whitney U test.

To investigate potential genetic redundancy or functional masking between fim and fim2, the competition assay was repeated in a fim-negative background. Consistent with previous data [23], bacterial counts were considerably lower in this fim-negative background experiment as compared to the initial competition assay. Infection was established in the bladders of five out of six mice, with a median bacterial count of 1.35 × 102 in these five mice. At time of sacrifice, infection had ascended into nine of ten kidneys with a median CFU count of 2.7 × 102 (n = 10). However, in all cases no bacteria were isolated from the urine suggesting counts of less than 50 per ml. The median CI value obtained for bladder samples showed that CFU counts for KR2107∆fim and KR2107∆fimfim2 did not differ significantly (Figure 8A). However, the median kidney CFU counts were 5.6-fold higher for the KR2107∆fim (1.4 × 102) than KR2107∆fimfim2 mutant (2.5 × 101), and although similar to the results obtained in the fim-positive background these results were also not statistically significant (P = 0.066) (Figure 8B). These results have confirmed the importance of fim in K. pneumoniae-mediated urovirulence and further support the case for a potential but subtle accessory role for fim2 in this disease process.

Discussion

The plastic nature of K. pneumoniae genomes is well described and an increasing number of studies have elucidated the function of various components of the accessory genome of the pyogenic liver abscess-associated strain K. pneumoniae NTUH-K2044. However, functional characterization of the accessory genome of strains associated with other types of infection is lacking. In order to investigate the plasticity of K. pneumoniae associated with other infections, we previously interrogated the pheV locus of sixteen clinical isolates from patients without pyogenic liver abscesses for the presence of foreign DNA elements [13]. In this study, further tRIP-PCR interrogation of K. pneumoniae KR116 using met56-specific primers identified a novel GI, KpGI-5, inserted within its met56 gene. KR116 had been isolated from the blood of a patient with pneumonia and neutropenic septicaemia. KpGI-5 was sequenced in this study and found to encode a putative γ1-type CU fimbrial operon that has been named fim2.

The genetic organization of fim2 resembles that of the K. pneumoniae fim operon and contains homologs of all eight fim genes. fim2 is predicted to code for a major fimbrial subunit (Fim2A), three minor fimbrial subunits (Fim2F, Fim2G, Fim2H) and homologs of the FimC and FimD chaperone and usher proteins, respectively, thus classifying this locus as a novel γ1-type CU operon that putatively encodes a fimbrial appendage [20]. A seventh predicted protein, Fim2I, exhibited 82% identity to FimI, a protein required for fimbrial biogenesis; however, the exact nature of this dependence remains unknown [42]. Amino acid sequences of the eight fim2 gene products showed 60 to 92% identity to cognate Fim proteins. Indeed, the two clusters would appear to be pseudoparalogs, homologs that appear to be paralogous but have ended up in the same genome by both vertical and horizontal gene transfer [43]. The unique evolutionary origins of the fim and fim2 cluster are further highlighted by differences in transcriptional control. The fim cluster is largely controlled by the FimB and FimE recombinases which together switch transcription on and off by inverting a 314 bp promoter-containing sequence called fimS that lies upstream of fimA[22]. Exact copies, genetic remnants or potential functional-replacements of the 9 bp fimS-flanking inverted repeats could not be identified within the putative fim2 promoter region that lies upstream of fim2A. Furthermore, as KpGI-5 lacks homologs of the FimB and FimE recombinases we conclude that fim2 expression is not controlled via a fimS-like switch mechanism. Additionally, the fim2K gene within the fim2 cluster encodes an EAL domain-containing protein that is similar to FimK, which has previously been shown to regulate type 1 fimbrial expression [31]. FimK was hypothesised to exert its influence via the hydrolysis of the intracellular messenger c-di-GMP, which is known to regulate expression of virulence genes, motility and biofilm formation in other bacteria [29]. The in vitro and in vivo function of Fim2K is currently under investigation.

Bacterial adhesion to and colonization of host cells is frequently mediated by a diverse assortment of afimbrial and fimbrial adhesins, each thought to possess a particular tissue tropism [19]. The vast majority of K. pneumoniae strains are able to produce type 1 fimbriae [37, 44]. These structures are associated with mannose-sensitive agglutination of guinea pig red blood cells, a phenotype caused by interaction of the adhesin subunit FimH with terminally-exposed mannose residues in N-linked oligosaccharides on cell surfaces [45]. Previously it has been shown that the FimH residues partaking in binding to mono- and tri-mannose moieties are highly conserved [45]. The specific binding properties of Fim2H, the putative Fim2 adhesin, remain to be identified but it is unlikely to bind to mannose since only four out of the 13 mono- and tri-mannose binding residues of FimH are strictly conserved in Fim2H [45]. This is also in agreement with the inability of E. coli HB101 expressing fim2 to agglutinate guinea pig red blood cells (data not shown), though the relevance of these data remain uncertain given the lack of visualisable fimbriae in this model.

Despite multiple attempts we were unable to visualize fimbrial structures using electron microscopy when the fim2 operon was over-expressed in E. coli HB101 and K. pneumoniae C3091ΔfimΔmrk. Paradoxically, biofilm forming ability appeared to be enhanced in this fim2-expressing E. coli strain. These results are similar to those of a study in which constitutive expression of four of seven E. coli CU fimbrial operons was shown to cause phenotypic alternations despite the fact that fimbrial appendages could not be visualized by electron microscopy [36]. Difficulty in visualisation of fimbriae by electron microscopy has also been described for the enterotoxigenic E. coli fimbriae CS3 and CS6 and the putative Stg fimbriae of Salmonella enterica serovar Typhi [4648]. Most interestingly, when the latter was expressed in a bald E. coli strain an enhanced ability to adhere to INT-407 epithelial cells was noted despite the absence of EM-observable fimbriae [48]. It is possible that the fim2 operon may code for a short and/or thin fimbrial structure that is not readily visualized by electron microscopy, or one that is extremely fragile. Conceivably, the hypothesized Fim2 appendages may be best expressed under biofilm-forming conditions, potentially explaining the enhanced biofilm-forming phenotype exhibited by HB101/pFim2-Ptrc, or in other specific in vivo environments. Alternatively, the putative phosphodiesterase Fim2K may regulate fim2 transcription and/or that of an unknown E. coli adherence factor via a c-di-GMP-dependent pathway. Indeed, heterologous expression of fim2K has been shown to complement a mutant lacking an EAL-bearing protein (van Aartsen and Rajakumar, unpublished data). Proposed future anti-Fim2A-based immunofluorescence and immunogold electron microscopy studies in addition to detailed characterisation of Fim2K will ultimately help determine the mechanism by which fim2 contributes to biofilm formation.

The genomes of E. coli K-12, E. coli O157:H7 and Salmonella Typhi possess numerous cryptic CU fimbrial operons that are tightly regulated and not expressed under the majority of in vitro conditions tested [35, 36, 49]. In this work, fim2-specific transcript was identified in standard laboratory culture but the amount detected was 30- to 90-fold lower than that identified for fim and mrk, respectively. Compared to the K. pneumoniae genome-averaged A + T content (~43%), fim2 is AT-rich (53%) and the putative promoter region upstream of fim2A possesses an even higher AT-content (73%). As moderate-to-marked upregulation of seven CU fimbrial operons has been reported in an E. coli K-12 H-NS mutant [36], the finding of an AT-rich fim2 promoter region suggests that the H-NS protein may play a role in controlling this operon as well. Moreover, H-NS has been shown to bind preferentially to regions of horizontally-acquired DNA in Salmonella Typhimurium and it is therefore possible this also occurs with KpGI-5 [50]. Furthermore, in addition to Fim2K, KpGI-5 also encodes two other potential regulators one or more of which could alter fim2 expression. By analogy with other CU systems, we propose that upregulation of fim2 expression and biosynthesis of Fim2 fimbriae is likely to be triggered by specific environmental conditions and involve a complex interplay of multiple transcriptional regulators such as H-NS, Fim2K and/or FimK, and levels of expression of other surface components, such as the capsule [31, 36, 38, 51]. It is important to note that even though fim2 lacks an invertible promoter switch, it may still be stochastically controlled by a bistable regulatory circuit such as the DNA methylation-based system described in detail for E. coli Pap fimbriae and it is therefore possible that single cell variants expressing fim2 may exist [51].

Analysis of three sequenced K. pneumoniae strains revealed that, in addition to the fim and mrk operons, these genomes collectively encode at least six other CU fimbrial systems [22, 23], one or more of which may perform an as-yet uncharacterised role in adhesion to target tissues. To investigate the role of fim2 in virulence, isogenic fim2 mutants were constructed and examined in three murine models, each focussed on primary infection of a distinct clinically-relevant anatomical site. Surprisingly, despite many fimbrial systems having been clearly implicated in virulence, we detected no clear evidence of attenuation (murine lung and urinary tract infection models) or reduction in colonizing ability (murine intestinal colonization model) in the fim2-negative strains studied.

Intriguingly, examination of bladder CFU count-based CIs for the urinary tract infection experiments hinted at a subtle role for fim2 in the colonization of bladder and kidney tissues. In both tissues, median wildtype CFU counts were approximately ten-fold higher than those of the fim2 mutant, although when performed in a fim negative background this difference was reversed and reduced in bladder and kidney samples, respectively. Nevertheless, the latter conflicting results may due to the markedly lower CFU counts obtained in the fim negative background. As shown by neutral CI values in the lung tissue but an approximately 100-fold higher median liver CFU count for KR2107 as compared to its isogenic fim2 mutant, the fim2 locus would appear to be involved in systemic dissemination and/or survival of K. pneumoniae following primary infection of the respiratory tract. However, given the noted lack of statistical significance, low numbers of mice examined and substantial mouse-to-mouse variation for these liver CFU data, no firm conclusions can be derived at present. As an aside, the previously demonstrated dramatic positive contribution of fim to urovirulence in this murine model was also shown to be the case in the KR2107 background [22, 23]. At an overview level, based on total CFU counts per liver and per kidney for the lung infection and ascending urinary tract infection models, respectively, there was a suggestion, though not supported statistically, of an ordered gradation amongst the four isogenic strains with the most-to-least virulent as follows: KR2107, KR2107∆fim2, KR2107∆fim and KR2107∆fimfim2. We speculate this relates to a Fim2-mediated enhancement of bacterial biofilm-forming-, adhesive- and/or invasive-potential under the in vivo conditions tested. In addition, the predicted influence of Fim2K on the c-di-GMP regulatory circuit, may itself impact on virulence via regulation of Fim2, Fim and/or other virulence factors.

The fim2 cluster was also assessed for its ability to contribute to biofilm formation. Gene knock-out experiments in KR2107 failed to reveal a role for fim2 in biofilm formation. However, the function of the product of fim2 may have been masked due to physical interference by the K. pneumoniae capsule, a phenomenon previously observed with type 1 fimbriae [38, 39]. Alternatively, it may be a function of limited fim2 expression under the in vitro conditions examined. Therefore, heterologous expression of fim2 in the afimbriate E. coli strain HB101 and the bald fim2-negative K. pneumoniae C3091∆fimmrk mutant was pursued. Yet again evidence of a fim2-associated phenotype was elusive and only apparent in HB101 and then too only when crystal violet-staining data were standardised for total pre-wash cell numbers. Attempts to alleviate the observed growth retardation associated with over-expression of fim2 in a HB101 background by reducing incubation temperature to 30°C and by providing rare tRNAs in trans were unsuccessful. Furthermore, the observed growth retardation was highly reproducible even when newly generated HB101 strains possessing independently-constructed pFim2-Ptrc plasmids were used instead (van Aartsen and Rajakumar, unpublished data). Thus, it would appear that over-expression of fim2 in HB101 was specifically responsible for this phenotype, though no comparable effect occurred with over-expression of fim.

The presence of fim2 in more than one species and its global spread suggests that this horizontally acquired locus has been maintained within a subset of the Klebsiella population due to positive selection. Hence, although the role fim2 remains elusive, given the glimpses of functionality hinted at by our data and the evolutionary survival of this multi-gene entity, we hypothesize that putative Fim2 contributes to pathogenesis of infection and/or environmental persistence, at least under highly specific conditions.

Conclusions

In conclusion, we have described the KpGI-5 island which possessed a novel γ1-type CU operon called fim2. Although fim2 was shown to be expressed at an mRNA level and its function was investigated using three distinct murine infection models, tissue culture experiments and biofilm assays, no obvious in vitro or in vivo role for the fim2 locus was identified, although there were subtle hints of involvement in urovirulence and in bacterial dissemination from the respiratory tract. Nevertheless, as fim2 was found in approximately 13% of Klebsiella spp. isolates examined, we propose that fim2 has the potential to contribute beneficially to its host Klebsiella strains at least under specific conditions.

Methods

Bacterial strains, plasmids, and growth media

Bacterial strains and plasmids used in this study are described in Table 3. K. pneumoniae KR116 is a human blood stream infection isolate obtained from the University Hospitals of Leicester. Unless otherwise specified, strains were routinely cultured at 37°C in LB medium supplemented with 50 μg/ml apramycin, 250 μg/ml ampicillin, 30 μg/ml chloramphenicol, 50 μg/ml kanamycin and/or 15 μg/ml tetracycline for K. pneumoniae, and 100 μg/ml ampicillin, 12.5 μg/ml chloramphenicol, 50 μg/ml kanamycin and/or 10 μg/ml tetracycline for E. coli.
Table 3

Bacterial strains and plasmids used in this study

Bacterial strain or plasmid

Relevant characteristicsa

Reference or Source

Bacterial strains

  

Escherichia coli

  

DH5α

F- φ80dlacZ∆M15 ∆(lacZYA-argF)U169 deoR recA1 endA1 hsdR17(rK-mK+) phoA supE44 λ- thi-1 gyrA96 relA1

[52]

HB101

F- mcrB mrr hsdS20(rB- mB-) recA13 leuB6 ara-14 proA2 lacY1 galK2 xyl-5 mtl-1 rpsL20(SmR) glnV44 λ-

[53]

CC118λpir

Δ(are-leu) araD ΔlacX74 galE galK phoA20 thi-1 rpsE rpoB argE(Am) recA1 λpir

[54]

S17-1λpir

F’ recA hsdR RP4-2 (Tc::Mu) (Km::Tn7) λpir

[55]

EPI300-T1R

F- mcrA Δ(mrr-hsdRMS-mcrBC) φ80dlacZΔM15

ΔlacX74 recA1 endA1 araD139 Δ(ara-leu)7697

galU galK λ- rpsL nupG trfA tonA dhfr

Epicentre

Klebsiella pneumoniae

  

C3091

Clinical urinary tract infection isolate; StR

[56]

C3091∆fim::tet∆mrk::kan

C3091 with fim and mrk clusters deleted; StR, TetR, KanR

[23]

KR116

Clinical blood stream infection isolate

This work

KR116 ∆fim2K::kan

KR116 with an insertion-deletion mutation in fim2K where 125 bp has been replaced by a kanamycin resistance cassette; KanR

This work

KR2107

Spontaneous streptomycin resistant derivative of KR116; StR

This work

KR2107∆fim

KR2107 with fim deleted; StR, TetR

This work

KR2107∆fim2

KR2107 with fim2 deleted; StR, KanR

This work

KR2107∆fimfim2

KR2107 with fim and fim2 deleted; StR, TetR, KanR

This work

Plasmids

  

pDS132

Lambda pir-based suicide vector; CmlR

[57]

pBluescript II KS+

High copy number cloning vector; AmpR

Fermentas

pWSK129

Low copy number cloning vector; KanR

[58]

pKOBEG-Apra

Lambda Red expression plasmid, PBAD promoter; AprR

[59]

pRT733

Source of KanR cassette; KanR

[60]

pCC2FOS

Fosmid cloning vector; CmlR

Epicentre

pTRC99a

IPTG inducible expression vector with PTRC promoter and lacI q ; AmpR

[61]

pJTOOL-7

Derivate of pTRC99a with an added NotI cut site in multiple the cloning site; AmpR

This work

pJKO-4a

pDS132 with SOE-PCR fragment for tagging of fim2K (fim2K::Kan); CmlR, KanR

This work

pJFos-1

40.6 kb fim2K::Kan-containing fragment cloned into pCC2FOS; CmlR, KanR

This work

pJFos-4

26.1 kb fim2K::Kan-containing fragment cloned into pCC2FOS; CmlR, KanR

This work

pFim2-HCN

9.4 kb PCR fragment containing the fim2 locus cloned into the NotI site of pBluescript II KS+; AmpR

This work

pFim2-LCN

9.4 kb PCR fragment containing the fim2 locus cloned into the NotI site of pWSK129; AmpR

This work

pFim2-Ptrc

9.0 kb PCR fragment containing the fim2 locus cloned into the NotI/SbfI site of pJTOOL-7. IPTG inducible; AmpR

This work

a Amp ampicillin; Apr apramycin; Cml chloramphenicol; Kan kanamycin; St streptomycin; Tet tetracycline. Superscript R indicates resistance.

DNA analysis and manipulations

Restriction enzymes and T4 DNA ligase were obtained from New England Biolabs and/or Promega and used according to manufacturer’s instructions. Genomic DNA and plasmid DNA were extracted using the ArchivePure DNA Purification Kit (5 PRIME) and GenElute™ Plasmid Miniprep Kit (Sigma), respectively. Primers used in this study are listed in Additional file 2: Table S1. Standard PCR amplification was carried out using GoTaq (Promega).

An 8.2 kb region containing the fim2 operon (fim2A-fim2K) was amplified from KR116 with primers PR937 and PR938 using KOD Hot Start polymerase (Merck), and cloned into the NotI site of pBluescript II KS + and pWSK129 to create high (pFim2-HCN) and low copy number (pFim2-LCN) plasmid clones, respectively. Additionally, the fim2 locus was amplified using primers PR1224 and PR1222 and was cloned into pJTOOL-7, a pTRC99a derivative, to create pFim2-Ptrc. A fosmid library representative of KR116 ∆fim2K::kan was constructed using the Epicentre Copy Control Fosmid Library Production kit, with some minor modifications. Briefly, 2.5 μg of genomic DNA was sheared to ~40 kb fragments by pipetting through a 200 μl tip. After end repair, the DNA was ligated into pCC2FOS and packaged into phages using MaxPlax Lambda Packaging Extracts (Epicentre) which were then used to infect E. coli EPI300-T1R. Marker rescue of kanamycin resistant fosmid clones was performed by plating infected EPI300-T1R cells on LB plates supplemented with chloramphenicol and kanamycin. Selected fosmids were subjected to approximately 60-fold coverage Roche 454 pyrosequencing (University of Leicester NUCLEUS Genomics Core Facility).

Construction of mutant strains

K. pneumoniae KR2107, a spontaneous streptomycin-resistant mutant of KR116, was used as the parent strain for all isogenic mutants. It possessed a 24 h growth curve identical to KR116 and agglutinated guinea pig red blood cells in a similar manner. fim2 was exchanged for a kanamycin resistance cassette by lambda Red-mediated recombination. KR2107 was transformed with pKOBEG-Apra, a temperature-sensitive plasmid encoding the lambda Red recombinase system, and grown at 30°C in LB media supplemented with apramycin and 0.2% arabinose. Electrocompetent KR2107/pKOBEG-Apra cells were prepared according to standard methods and electroporated with an SOE-PCR product comprising a kanamycin resistance gene cassette and targeting flanking homologous sequences (Additional file 1: Figure S1). The KR2107∆fim2 mutant was obtained by selecting on LB media plus kanamycin at 37°C. Loss of pKOBEG-Apra was confirmed by reversion to apramycin sensitivity and a negative PCR with primers EBGNHe and EBGh3. The KR2107∆fim2 mutant was validated by PCR analysis using primer pairs PR1103-Kn2 (2590 bp) and Kn1-PR1104 (3903 bp). The 2095 bp ∆fim::tet fragment was amplified from C3091∆fim::tet∆mrk::kan using primers UpfimB-F and DwfimK-R and electroporated into arabinose-induced KR2107/pKOBEG-Apra to construct the fim mutant [23]. KR2107∆fimfim2 was constructed similarly from a KR2107∆fim/pKOBEG-Apra intermediate strain. KR116 ∆fim2K::kan was constructed by conjugative transfer of the suicide construct pJKO-4a to facilitate allelic exchange ([62]; Additional file 1: Figure S1).

Transcriptional analysis of fim2

Total RNA was prepared from KR2107 after growing for 16 h in LB liquid medium (37°C, 200 rpm) using the Norgen Total RNA Purification Kit. The Ambion TURBO DNA-free kit was used to remove residual DNA and cDNA libraries synthesised using the QuantiTect Reverse Transcription kit (Qiagen) as recommended by the manufacturer. An identical reaction without reverse transcriptase was performed to assess DNA contamination. Regions corresponding to fim2A, fim2H and fim2K were PCR amplified using primers pairs PR1607-PR1608, PR1609-PR1610, and PR1611-PR1612, respectively. Regions linking 116met56-10 to fim2A and fim2H to fim2K were detected using primer pairs PR1626-PR1627 and PR16268-PR1629, respectively. Amplicons were visualised on 1.5% agarose gels.

Transmission electron microscopy

Five μl of sample was applied to a hydrophilic Formvar-carbon coated copper grid (Agar Scientific) and allowed to adsorb for 5 min. After wicking excess liquid, the grid was washed once using distilled deionised water and then negative-stained for 15 s with a droplet of 1% uranyl acetate (pH 4.5). Electron microscopy was performed on a JEOL JEM-1400 microscope at 80 kV.

Biofilm, growth curve and epithelial adhesion assays

Biofilm assays were performed using a modified microtiter plate-based method [63]. Briefly, strains were grown for 16 h (37°C, 200 rpm) in LB broth with antibiotics if necessary and subcultured 1:100 into 100 μl LB medium with 0.05 mM IPTG and ampicillin, when required, in 96-well microtiter plates (Nunc). Plates were incubated statically for 48 h at 37°C and OD595 (optical density at 595 nm) readings obtained at the end of incubation. Following incubation the medium was removed and the plate washed once with distilled water. 125 μl of 0.1% (v/v) crystal violet was added to each well and left to stain for 10 min. The plate was then washed twice with distilled water, dried thoroughly and the stain eluted with 200 μl of 95% ethanol per well and the absorbance measured at 595 nm (BioRad Model 680 Microplate reader). Each was strain tested in eight wells and three replicate experiments were performed.

Growth curves were performed similarly to biofilm assays with a few minor modifications. Plates were incubated statically for 24 h at 37°C in a Varioskan (Thermo Scientific) instrument. The plates were subjected to a brief vigorous shake every 10 min immediately prior to the absorbance being measured at 600 nm (OD600). Each strain was tested in seven wells and two duplicate experiments were performed.

Quantitative assessment of bacterial adhesion to epithelial cells was performed using human HCT-8 ileocaecal and 5637 bladder cells. HCT-8 cells were subcultivated (1:10) twice a week in RPMI 1640 medium containing 25 mM HEPES, 2 mM glutamine, 1 mM pyruvate, 10% fetal calf serum, 0.002% neomycin and 0.01% streptomycin. 5637 cells were cultivated similarly but no pyruvate was added to the medium. Epithelial cells were seeded into two 24-well tissue culture plates (Nunc) and grown to confluent monolayers. After carefully washing each well three times with warm PBS, 1 ml of fresh supplement-free RPMI 1640 was added and inoculated with ~2 × 106 CFU from an overnight culture. Plates were incubated for 3 h at 37°C. One plate was then used to determine the total number of bacteria at the end of 3 h incubation, as described previously [56]. The wells in the second plate were carefully washed three times with PBS and then used to determine the total number of adherent bacteria. All assays were performed in duplicate and repeated independently four times.

Murine models of infection

Six- to eight-week-old female CFW1 mice (Harlan) were used for intestinal colonization experiments as described previously [64]. Briefly, mice were provided with drinking water containing 5 g/l streptomycin sulphate for 24 h and fed a 100 μl suspension containing ~109 CFU of each strain in 20% sucrose. On indicated days, faecal pellets were collected, weighed and homogenised in 0.9% NaCl and dilutions plated onto MacConkey agar supplemented with appropriate antibiotics for faecal CFU counts.

A previously described intranasal infection model was used in a co-infection format [23]. Six- to eight-week-old female NMRi mice (Harlan) were anaesthetized and hooked on a string by their front teeth. 50 μl of bacterial suspension containing ~5 × 107 CFU of each strain was dropped onto the nares to allow for aspiration. Mice were left hooked on the string for 10 min before being returned to their cages. At sacrifice lungs, spleen and liver were collected in 0.9% NaCl and homogenised. Serial dilutions were plated on selective media for CFU counts.

The ascending urinary tract infection model in which C3H mice (Harlan) were inoculated transurethrally with 50 μl of bacterial suspension containing ~5 × 108 CFU bacteria has been described in detail previously [22, 65]. All animal experiments were conducted under the auspices of the Animal Experiments Inspectorate, the Danish Ministry of Justice.

Data analysis, statistics and nucleotide accession number

Nucleotide sequences were annotated and analysed using the Integrative Services for Genomic Analysis software and manually curated [66]. The competitive index (CI) was calculated by dividing the ratio of fim2-positive to fim2-negative bacteria recovered from infected organs by the ratio of the corresponding bacteria in the initial inoculum. The non-parametric Mann–Whitney U test was used to analyse infection data. Biofilm and cell-adhesion data were analysed using the non-parametric Kruskal-Wallis test and Dunn’s posthoc analysis. The nucleotide sequence of KpGI-5 has been deposited online [GenBank: JN181158].

Declarations

Acknowledgements

We thank Jean-Marc Ghigo, Unité de Génétique des Biofilms, Institut Pasteur, France, for providing pKOBEG-Apra and Stefan Hyman, Centre for Core Biotechnology Services, University of Leicester, for electron microscopy analysis. This study was supported by a Medisearch research grant. JJvA was supported by a University of Leicester, 50th Anniversary PhD Scholarship. SGS was partially supported by the Danish Research Agency grant 2101-06-0009. HYO was supported by the National Natural Science Foundation of China (30871345), the Program for New Century Excellent Talents in University, MOE, China (NCET-10-0572) and the Program for Chen Xing Scholars, Shanghai Jiaotong University.

Authors’ Affiliations

(1)
Department of Infection, Immunity and Inflammation, University of Leicester
(2)
Department of Microbiological Surveillance and Research, Statens Serum Institut
(3)
State Key Laboratory of Microbial Metabolism, Shanghai Jiaotong University
(4)
Department of Clinical Microbiology, University Hospitals of Leicester NHS Trust

References

  1. Podschun R, Ullmann U: Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev. 1998, 11: 589-603.PubMedPubMed CentralGoogle Scholar
  2. Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan R, Chaudhary U, Doumith M, Giske CG, Irfan S: Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis. 2010, 10: 597-602. 10.1016/S1473-3099(10)70143-2.PubMedPubMed CentralView ArticleGoogle Scholar
  3. Hirsch EB, Tam VH: Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection. J Antimicrob Chemother. 2010, 65: 1119-1125. 10.1093/jac/dkq108.PubMedView ArticleGoogle Scholar
  4. Tsai F-C: Pyogenic Liver Abscess as Endemic Disease. Taiwan Emerging Infect Dis. 2008, 14: 1592-1600. 10.3201/eid1410.071254.View ArticleGoogle Scholar
  5. Sobirk SK, Struve C, Jacobsson SG: Primary Klebsiella pneumoniae Liver Abscess with Metastatic Spread to Lung and Eye, a North-European Case Report of an Emerging Syndrome. Open Microbiol J. 2010, 4: 5-7. 10.2174/1874285801004010005.PubMedPubMed CentralView ArticleGoogle Scholar
  6. Nadasy KA, Domiati-Saad R, Tribble MA: Invasive Klebsiella pneumoniae Syndrome in North America. Clin Infect Dis. 2007, 45: e25-e28. 10.1086/519424.PubMedView ArticleGoogle Scholar
  7. Cortés G, Borrell N, de Astorza B, Gómez C, Sauleda J, Albertí S: Molecular analysis of the contribution of the capsular polysaccharide and the lipopolysaccharide O side chain to the virulence of Klebsiella pneumoniae in a murine model of pneumonia. Infect Immun. 2002, 70: 2583-2590. 10.1128/IAI.70.5.2583-2590.2002.PubMedPubMed CentralView ArticleGoogle Scholar
  8. Bachman MA, Oyler JE, Burns SH, Caza M, Lepine F, Dozois CM, Weiser JN: Klebsiella pneumoniae Yersiniabactin predisposes to respiratory tract infection through evasion of Lipocalin 2. Infect Immun. 2011, 79: 3309-3316. 10.1128/IAI.05114-11.PubMedPubMed CentralView ArticleGoogle Scholar
  9. Chou HC, Lee CZ, Ma LC, Fang CT, Chang SC, Wang JT: Isolation of a chromosomal region of Klebsiella pneumoniae associated with allantoin metabolism and liver infection. Infect Immun. 2004, 72: 3783-3792. 10.1128/IAI.72.7.3783-3792.2004.PubMedPubMed CentralView ArticleGoogle Scholar
  10. Chen Y-T, Liao T-L, Wu K-M, Lauderdale T-L, Yan J-J, Huang I-W, Lu M-C, Lai Y-C, Liu Y-M, Shu H-Y, Wang J-T, Su I-J, Tsai S-F: Genomic diversity of citrate fermentation in Klebsiella pneumoniae. BMC Microbiol. 2009, 9: 168-10.1186/1471-2180-9-168.PubMedPubMed CentralView ArticleGoogle Scholar
  11. Ma LC, Fang CT, Lee CZ, Shun CT, Wang JT: Genomic heterogeneity in Klebsiella pneumoniae strains is associated with primary pyogenic liver abscess and metastatic infection. J Infect Dis. 2005, 192: 117-128. 10.1086/430619.PubMedView ArticleGoogle Scholar
  12. Chen N, Ou H-Y, van Aartsen JJ, Jiang X, Li M, Yang Z, Wei Q, Chen X, He X, Deng Z, Rajakumar K, Lu Y: The pheV phenylalanine tRNA gene in Klebsiella pneumoniae clinical isolates is an integration hotspot for possible niche-adaptation genomic islands. Curr Microbiol. 2010, 60: 210-216. 10.1007/s00284-009-9526-4.PubMedView ArticleGoogle Scholar
  13. van Aartsen JJ: The Klebsiella pheV tRNA locus: a hotspot for integration of alien genomic islands. Bioscience Horizons. 2008, 1: 51-60. 10.1093/biohorizons/hzn006.View ArticleGoogle Scholar
  14. Ou HY, He X, Harrison EM, Kulasekara BR, Thani AB, Kadioglu A, Lory S, Hinton JC, Barer MR, Deng Z, Rajakumar K: MobilomeFINDER: web-based tools for in silico and experimental discovery of bacterial genomic islands. Nucleic Acids Res. 2007, 35: W97-W104. 10.1093/nar/gkm380.PubMedPubMed CentralView ArticleGoogle Scholar
  15. Zhang J, van Aartsen JJ, Jiang X, Shao Y, Tai C, He X, Tan Z, Deng Z, Jia S, Rajakumar K, et al: Expansion of the known Klebsiella pneumoniae species gene pool by characterization of novel alien DNA islands integrated into tmRNA gene sites. J Microbiol Methods. 2010, 84: 283-289.PubMedView ArticleGoogle Scholar
  16. Hacker J, Carniel E: Ecological fitness, genomic islands and bacterial pathogenicity. A Darwinian view of the evolution of microbes. EMBO Rep. 2001, 2: 376-381.PubMedPubMed CentralView ArticleGoogle Scholar
  17. Gal-Mor O, Finlay BB: Pathogenicity islands: a molecular toolbox for bacterial virulence. Cell Microbiol. 2006, 8: 1707-1719. 10.1111/j.1462-5822.2006.00794.x.PubMedView ArticleGoogle Scholar
  18. Montgomerie JZ: Epidemiology of Klebsiella and hospital-associated infections. Rev Infect Dis. 1979, 1: 736-753. 10.1093/clinids/1.5.736.PubMedView ArticleGoogle Scholar
  19. Pizarro-Cerdá J, Cossart P: Bacterial adhesion and entry into host cells. Cell. 2006, 124: 715-727. 10.1016/j.cell.2006.02.012.PubMedView ArticleGoogle Scholar
  20. Nuccio SP, Bäumler AJ: Evolution of the chaperone/usher assembly pathway: fimbrial classification goes Greek. Microbiol Mol Biol Rev. 2007, 71: 551-575. 10.1128/MMBR.00014-07.PubMedPubMed CentralView ArticleGoogle Scholar
  21. Di Martino P, Cafferini N, Joly B, Darfeuille-Michaud A: Klebsiella pneumoniae type 3 pili facilitate adherence and biofilm formation on abiotic surfaces. Res Microbiol. 2003, 154: 9-16. 10.1016/S0923-2508(02)00004-9.PubMedView ArticleGoogle Scholar
  22. Struve C, Bojer M, Krogfelt KA: Characterization of Klebsiella pneumoniae type 1 fimbriae by detection of phase variation during colonization and infection and impact on virulence. Infect Immun. 2008, 76: 4055-4065. 10.1128/IAI.00494-08.PubMedPubMed CentralView ArticleGoogle Scholar
  23. Struve C, Bojer M, Krogfelt KA: Identification of a conserved chromosomal region encoding Klebsiella pneumoniae type 1 and type 3 fimbriae and assessment of the role of fimbriae in pathogenicity. Infect Immun. 2009, 77: 5016-5024. 10.1128/IAI.00585-09.PubMedPubMed CentralView ArticleGoogle Scholar
  24. Tarkkanen AM, Virkola R, Clegg S, Korhonen TK: Binding of the type 3 fimbriae of Klebsiella pneumoniae to human endothelial and urinary bladder cells. Infect Immun. 1997, 65: 1546-1549.PubMedPubMed CentralGoogle Scholar
  25. Waksman G, Hultgren SJ: Structural biology of the chaperone-usher pathway of pilus biogenesis. Nat Rev Microbiol. 2009, 7: 765-774. 10.1038/nrmicro2220.PubMedPubMed CentralView ArticleGoogle Scholar
  26. Wu C-C, Huang Y-J, Fung C-P, Peng H-L: Regulation of the Klebsiella pneumoniae Kpc fimbriae by the site-specific recombinase KpcI. Microbiology. 2010, 156: 1983-1992. 10.1099/mic.0.038158-0.PubMedView ArticleGoogle Scholar
  27. Townsend SM, Kramer NE, Edwards R, Baker S, Hamlin N, Simmonds M, Stevens K, Maloy S, Parkhill J, Dougan G: Salmonella enterica serovar Typhi possesses a unique repertoire of fimbrial gene sequences. Infect Immun. 2001, 69: 2894-2901. 10.1128/IAI.69.5.2894-2901.2001.PubMedPubMed CentralView ArticleGoogle Scholar
  28. Simm R, Morr M, Kader A, Nimtz M, Romling U: GGDEF and EAL domains inversely regulate cyclic di-GMP levels and transition from sessility to motility. Mol Microbiol. 2004, 53: 1123-1134. 10.1111/j.1365-2958.2004.04206.x.PubMedView ArticleGoogle Scholar
  29. Hengge R: Principles of c-di-GMP signalling in bacteria. Nat Rev Microbiol. 2009, 7: 263-273. 10.1038/nrmicro2109.PubMedView ArticleGoogle Scholar
  30. Schirmer T, Jenal U: Structural and mechanistic determinants of c-di-GMP signalling. Nat Rev Microbiol. 2009, 7: 724-735. 10.1038/nrmicro2203.PubMedView ArticleGoogle Scholar
  31. Rosen DA, Pinkner JS, Jones JM, Walker JN, Clegg S, Hultgren SJ: Utilization of an intracellular bacterial community pathway in Klebsiella pneumoniae urinary tract infection and the effects of FimK on type 1 pilus expression. Infect Immun. 2008, 76: 3337-3345. 10.1128/IAI.00090-08.PubMedPubMed CentralView ArticleGoogle Scholar
  32. Sommerfeldt N, Possling A, Becker G, Pesavento C, Tschowri N, Hengge R: Gene expression patterns and differential input into curli fimbriae regulation of all GGDEF/EAL domain proteins in Escherichia coli. Microbiology. 2009, 155: 1318-1331. 10.1099/mic.0.024257-0.PubMedView ArticleGoogle Scholar
  33. Hansen DS, Aucken HM, Abiola T, Podschun R: Recommended test panel for differentiation of Klebsiella species on the basis of a trilateral interlaboratory evaluation of 18 biochemical tests. J Clin Microbiol. 2004, 42: 3665-3669. 10.1128/JCM.42.8.3665-3669.2004.PubMedPubMed CentralView ArticleGoogle Scholar
  34. Schurtz TA, Hornick DB, Korhonen TK, Clegg S: The type 3 fimbrial adhesin gene (mrkD) of Klebsiella species is not conserved among all fimbriate strains. Infect Immun. 1994, 62: 4186-4191.PubMedPubMed CentralGoogle Scholar
  35. Low AS, Holden N, Rosser T, Roe AJ, Constantinidou C, Hobman JL, Smith DGE, Low JC, Gally DL: Analysis of fimbrial gene clusters and their expression in enterohaemorrhagic Escherichia coli O157:H7. Environ Microbiol. 2006, 8: 1033-1047. 10.1111/j.1462-2920.2006.00995.x.PubMedView ArticleGoogle Scholar
  36. Korea C-G, Ghigo J-M, Beloin C: The sweet connection: Solving the riddle of multiple sugar-binding fimbrial adhesins in Escherichia coli: Multiple E. coli fimbriae form a versatile arsenal of sugar-binding lectins potentially involved in surface-colonisation and tropism. BioEssays. 2011, 33: 300-311. 10.1002/bies.201000121.PubMedView ArticleGoogle Scholar
  37. Struve C, Krogfelt KA: Pathogenic potential of environmental Klebsiella pneumoniae isolates. Environ Microbiol. 2004, 6: 584-590. 10.1111/j.1462-2920.2004.00590.x.PubMedView ArticleGoogle Scholar
  38. Schembri MA, Blom J, Krogfelt KA, Klemm P: Capsule and fimbria interaction in Klebsiella pneumoniae. Infect Immun. 2005, 73: 4626-4633. 10.1128/IAI.73.8.4626-4633.2005.PubMedPubMed CentralView ArticleGoogle Scholar
  39. Struve C, Krogfelt KA: Role of capsule in Klebsiella pneumoniae virulence: lack of correlation between in vitro and in vivo studies. FEMS Microbiol Lett. 2003, 218: 149-154. 10.1111/j.1574-6968.2003.tb11511.x.PubMedView ArticleGoogle Scholar
  40. Lawlor MS, Hsu J, Rick PD, Miller VL: Identification of Klebsiella pneumoniae virulence determinants using an intranasal infection model. Mol Microbiol. 2005, 58: 1054-1073. 10.1111/j.1365-2958.2005.04918.x.PubMedView ArticleGoogle Scholar
  41. Lau HY, Clegg S, Moore TA: Identification of Klebsiella pneumoniae genes uniquely expressed in a strain virulent using a murine model of bacterial pneumonia. Microb Pathog. 2007, 42: 148-155. 10.1016/j.micpath.2007.01.001.PubMedPubMed CentralView ArticleGoogle Scholar
  42. Valenski ML, Harris SL, Spears PA, Horton JR, Orndorff PE: The Product of the fimI gene is necessary for Escherichia coli type 1 pilus biosynthesis. J Bacteriol. 2003, 185: 5007-5011. 10.1128/JB.185.16.5007-5011.2003.PubMedPubMed CentralView ArticleGoogle Scholar
  43. Koonin EV: Orthologs, paralogs, and evolutionary genomics. Annu Rev Genet. 2005, 39: 309-338. 10.1146/annurev.genet.39.073003.114725.PubMedView ArticleGoogle Scholar
  44. Podschun R, Pietsch S, Holler C, Ullmann U: Incidence of Klebsiella species in surface waters and their expression of virulence factors. Appl Environ Microbiol. 2001, 67: 3325-3327. 10.1128/AEM.67.7.3325-3327.2001.PubMedPubMed CentralView ArticleGoogle Scholar
  45. Stahlhut SG, Tchesnokova V, Struve C, Weissman SJ, Chattopadhyay S, Yakovenko O, Aprikian P, Sokurenko EV, Krogfelt KA: Comparative structure-function analysis of mannose-specific FimH adhesins from Klebsiella pneumoniae and Escherichia coli. J Bacteriol. 2009, 191: 6592-6601. 10.1128/JB.00786-09.PubMedPubMed CentralView ArticleGoogle Scholar
  46. Lüdi S, Frey J, Favre D, Stoffel MH: Assessing the expression of enterotoxigenic Escherichia coli-specific surface antigens in recombinant strains by transmission electron microscopy and immunolabeling. J Histochem Cytochem. 2006, 54: 473-477. 10.1369/jhc.5A6794.2005.PubMedView ArticleGoogle Scholar
  47. Knutton S, Lloyd DR, McNeish AS: Identification of a new fimbrial structure in enterotoxigenic Escherichia coli (ETEC) serotype O148:H28 which adheres to human intestinal mucosa: a potentially new human ETEC colonization factor. Infect Immun. 1987, 55: 86-92.PubMedPubMed CentralGoogle Scholar
  48. Forest C, Faucher SP, Poirier K, Houle S, Dozois CM, Daigle F: Contribution of the stg fimbrial operon of Salmonella enterica serovar Typhi during interaction with human cells. Infect Immun. 2007, 75: 5264-5271. 10.1128/IAI.00674-07.PubMedPubMed CentralView ArticleGoogle Scholar
  49. Humphries AD, Raffatellu M, Kingsley Ra, Droleskey R, Zhang S, Figueiredo J, Khare S, Nunes J, Adams LG, Tsolis RM, Bäumler AJ: The use of flow cytometry to detect expression of subunits encoded by 11 Salmonella enterica serotype Typhimurium fimbrial operons. Mol Microbiol. 2003, 48: 1357-1376. 10.1046/j.1365-2958.2003.03507.x.PubMedView ArticleGoogle Scholar
  50. Lucchini S, Rowley G, Goldberg MD, Hurd D, Harrison M, Hinton JCD: H-NS mediates the silencing of laterally acquired genes in bacteria. PLoS Pathog. 2006, 2: e81-10.1371/journal.ppat.0020081.PubMedPubMed CentralView ArticleGoogle Scholar
  51. Clegg S, Wilson J, Johnson J: More than one way to control hair growth: regulatory mechanisms in enterobacteria that affect fimbriae assembled by the chaperone/usher pathway. J Bacteriol. 2011, 193: 2081-2088. 10.1128/JB.00071-11.PubMedPubMed CentralView ArticleGoogle Scholar
  52. Hanahan D: Studies on transformation of Escherichia coli with plasmids. J Mol Biol. 1983, 166: 557-580. 10.1016/S0022-2836(83)80284-8.PubMedView ArticleGoogle Scholar
  53. Boyer HW, Roulland-Dussoix D: A complementation analysis of the restriction and modification of DNA in Escherichia coli. J Mol Biol. 1969, 41: 459-472. 10.1016/0022-2836(69)90288-5.PubMedView ArticleGoogle Scholar
  54. Herrero M, de Lorenzo V, Timmis KN: Transposon vectors containing non-antibiotic resistance selection markers for cloning and stable chromosomal insertion of foreign genes in Gram-negative bacteria. J Bacteriol. 1990, 172: 6557-6567.PubMedPubMed CentralGoogle Scholar
  55. Simon R, Priefer U, Pühler A: A Broad Host Range Mobilization System for In Vivo Genetic Engineering: Transposon Mutagenesis in Gram Negative Bacteria. Bio/Technology. 1983, 1: 784-791. 10.1038/nbt1183-784.View ArticleGoogle Scholar
  56. Oelschlaeger TA, Tall BD: Invasion of cultured human epithelial cells by Klebsiella pneumoniae isolated from the urinary tract. Infect Immun. 1997, 65: 2950-2958.PubMedPubMed CentralGoogle Scholar
  57. Philippe N, Alcaraz JP, Coursange E, Geiselmann J, Schneider D: Improvement of pCVD442, a suicide plasmid for gene allele exchange in bacteria. Plasmid. 2004, 51: 246-255. 10.1016/j.plasmid.2004.02.003.PubMedView ArticleGoogle Scholar
  58. Wang RF, Kushner SR: Construction of versatile low-copy-number vectors for cloning, sequencing and gene expression in Escherichia coli. Gene. 1991, 100: 195-199.PubMedView ArticleGoogle Scholar
  59. Chaveroche M, Ghigo J, D’Enfert C: A rapid method for efficient gene replacement in the filamentous fungus Aspergillus nidulans. Nucleic Acids Res. 2000, 28: E97-10.1093/nar/28.22.e97.PubMedPubMed CentralView ArticleGoogle Scholar
  60. Taylor RK, Manoil C, Mekalanos JJ: Broad-host-range vectors for delivery of TnphoA: use in genetic analysis of secreted virulence determinants of Vibrio cholerae. J Bacteriol. 1989, 171: 1870-1878.PubMedPubMed CentralGoogle Scholar
  61. Amann E, Ochs B, Abel KJ: Tightly regulated tac promoter vectors useful for the expression of unfused and fused proteins in Escherichia coli. Gene. 1988, 69: 301-315. 10.1016/0378-1119(88)90440-4.PubMedView ArticleGoogle Scholar
  62. van Aartsen JJ, Rajakumar K: An optimized method for suicide vector-based allelic exchange in Klebsiella pneumoniae. J Microbiol Methods. 2011, 86: 313-319. 10.1016/j.mimet.2011.06.006.PubMedView ArticleGoogle Scholar
  63. O’Toole G, Kolter R: Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis. Mol Microbiol. 1998, 28: 449-461. 10.1046/j.1365-2958.1998.00797.x.PubMedView ArticleGoogle Scholar
  64. Licht TR, Krogfelt KA, Cohen PS, Poulsen LK, Urbance J, Molin S: Role of lipopolysaccharide in colonization of the mouse intestine by Salmonella typhimurium studied by in situ hybridization. Infect Immun. 1996, 64: 3811-3817.PubMedPubMed CentralGoogle Scholar
  65. Hvidberg H, Struve C, Krogfelt KA, Christensen N, Rasmussen SN, Frimodt-Møller N: Development of a long-term ascending urinary tract infection mouse model for antibiotic treatment studies. Antimicrob Agents Chemother. 2000, 44: 156-163. 10.1128/AAC.44.1.156-163.2000.PubMedPubMed CentralView ArticleGoogle Scholar
  66. Hemmerich C, Buechlein A, Podicheti R, Revanna KV, Dong Q: An Ergatis-based prokaryotic genome annotation web server. Bioinformatics. 2010, 26: 1122-1124. 10.1093/bioinformatics/btq090.PubMedView ArticleGoogle Scholar

Copyright

© van Aartsen et al; licensee BioMed Central Ltd. 2012

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement